DOID:0050687: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
|name=cell type cancer | |name=cell type cancer | ||
|namespace=disease_ontology | |namespace=disease_ontology | ||
|def="A cancer that is classified by the type of cell from which it is derived." [url:http | |def="A cancer that is classified by the type of cell from which it is derived." [url:http://cancerguide.org/basic.html, url:http://en.wikipedia.org/wiki/Cancer] | ||
|xref= | |xref= | ||
|is_a=DOID:162 | |is_a=DOID:162 | ||
| Line 14: | Line 14: | ||
|obo_creation_date=2011-06-13T03:28:50Z | |obo_creation_date=2011-06-13T03:28:50Z | ||
|subset= | |subset= | ||
|derives_from= | |derives_from= | ||
|develops_from= | |develops_from= | ||
Revision as of 16:31, 26 June 2012
| Name: | cell type cancer |
|---|---|
| Namespace: | disease_ontology |
| Definition: | "A cancer that is classified by the type of cell from which it is derived." [url:http://cancerguide.org/basic.html, url:http://en.wikipedia.org/wiki/Cancer] |
| Created by: | snadendla |
| Creation date: | 2011-06-13T03:28:50Z |
Ontology association<br>Each term has an is_a parent in the Disease Ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to DISEASE ontologies.<br><br>link to ontology dataset<br>data
Parents
| is_a: | DOID:162(cancer) |
|---|
Children
| is a: | DOID:1115 (sarcoma),DOID:154 (mixed cell type cancer),DOID:1909 (melanoma),DOID:2994 (germ cell cancer),DOID:305 (carcinoma),DOID:3070 (malignant glioma),DOID:3350 (mesenchymal cell neoplasm) |
|---|
Ontology Tree: Loaded from BioPortal
Ontorolgy tree(Small window open)
FF samples
Human (Homo sapiens)
- 10408-106B3 (lung adenocarcinoma cell line:PC-14)
- 10410-106B5 (extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS)
- 10411-106B6 (renal cell carcinoma cell line:OS-RC-2)
- 10412-106B7 (malignant trichilemmal cyst cell line:DJM-1)
- 10415-106C1 (gall bladder carcinoma cell line:TGBC2TKB)
- 10417-106C3 (papillotubular adenocarcinoma cell line:TGBC18TKB)
- 10418-106C4 (transitional-cell carcinoma cell line:5637)
- 10419-106C5 (breast carcinoma cell line:MDA-MB-453)
- 10420-106C6 (colon carcinoma cell line:COLO-320)
- 10423-106C9 (choriocarcinoma cell line:BeWo)
... further results Mouse (Mus musculus)
- 10408-106B3 (lung adenocarcinoma cell line:PC-14)
- 10410-106B5 (extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS)
- 10411-106B6 (renal cell carcinoma cell line:OS-RC-2)
- 10412-106B7 (malignant trichilemmal cyst cell line:DJM-1)
- 10415-106C1 (gall bladder carcinoma cell line:TGBC2TKB)
- 10417-106C3 (papillotubular adenocarcinoma cell line:TGBC18TKB)
- 10418-106C4 (transitional-cell carcinoma cell line:5637)
- 10419-106C5 (breast carcinoma cell line:MDA-MB-453)
- 10420-106C6 (colon carcinoma cell line:COLO-320)
- 10423-106C9 (choriocarcinoma cell line:BeWo)
Enrichment analysis: top 100 FFCP enriched with this ontology termTOP 100 FANTOM5 Cage Peaks enriched with DOID:0050687 (cell type cancer), sorted by p-values <br>Analyst: Hideya Kawaji<br><br>link to source dataset <br>human : data <br>mouse : data
| P-value | FFCP | Short description |
|---|---|---|
| 7.3e-52 | FFCP PHASE1:Hg19::chr9:97317348..97317379,+#_5476a99a4e92b3b9316ca013ad512187 | p1@uc004aus.1 |
| 7.3e-52 | FFCP PHASE2:Hg19::chr9:97317348..97317379,+#_5476a99a4e92b3b9316ca013ad512187 | p1@uc004aus.1 |
| 1.13e-48 | FFCP PHASE2:Hg19::chr7:156803329..156803362,-#_6c1bb7a6cf1312b0bcd487a9f91851b4 | p1@MNX1 |
| 1.13e-48 | FFCP PHASE1:Hg19::chr7:156803329..156803362,-#_6c1bb7a6cf1312b0bcd487a9f91851b4 | p1@MNX1 |
| 2.83e-48 | FFCP PHASE1:Hg19::chrX:153991088..153991168,+#_517cc3607d1ab1f7a8acfdf86512216f | p1@DKC1 |
| 2.83e-48 | FFCP PHASE2:Hg19::chrX:153991088..153991168,+#_517cc3607d1ab1f7a8acfdf86512216f | p1@DKC1 |
| 1.03e-46 | FFCP PHASE1:Hg19::chr12:20975472..20975489,+#_00e6f627fb3ec852eabd73be89c7ca29 | p@chr12:20975472..20975489, + |
| 1.03e-46 | FFCP PHASE2:Hg19::chr12:20975472..20975489,+#_00e6f627fb3ec852eabd73be89c7ca29 | p@chr12:20975472..20975489, + |
| 5.89e-46 | FFCP PHASE1:Hg19::chr20:57617831..57617909,-#_65f7279e60545754a324acde930dfe78 | p1@SLMO2 |
| 5.89e-46 | FFCP PHASE2:Hg19::chr20:57617831..57617909,-#_65f7279e60545754a324acde930dfe78 | p1@SLMO2 |
| 7.24e-46 | FFCP PHASE2:Hg19::chr7:1595871..1595896,-#_ee1f3964d0e3838cc1462a94e118c677 | p5@TMEM184A |
| 7.24e-46 | FFCP PHASE1:Hg19::chr7:1595871..1595896,-#_ee1f3964d0e3838cc1462a94e118c677 | p5@TMEM184A |
| 2.27e-45 | FFCP PHASE2:Hg19::chr8:120221345..120221393,+#_3d8132f22613bd0605544cd814d673bd | p3@MAL2 |
| 2.27e-45 | FFCP PHASE1:Hg19::chr8:120221345..120221393,+#_3d8132f22613bd0605544cd814d673bd | p3@MAL2 |
| 2.41e-45 | FFCP PHASE2:Hg19::chr11:1372935..1372952,+#_98f13140051ce854c8ac673ac299e9e3 | p@chr11:1372935..1372952, + |
| 2.41e-45 | FFCP PHASE1:Hg19::chr11:1372935..1372952,+#_98f13140051ce854c8ac673ac299e9e3 | p@chr11:1372935..1372952, + |
| 4.37e-45 | FFCP PHASE2:Hg19::chr3:180707436..180707451,-#_b19caebb5779f3793d0a43d63d5f97a7 | p2@DNAJC19 |
| 4.37e-45 | FFCP PHASE1:Hg19::chr3:180707436..180707451,-#_b19caebb5779f3793d0a43d63d5f97a7 | p2@DNAJC19 |
| 4.42e-45 | FFCP PHASE2:Hg19::chr3:172468505..172468582,+#_9662599a95471f6b573e63dcf691b7e0 | p1@ECT2 |
| 4.42e-45 | FFCP PHASE1:Hg19::chr3:172468505..172468582,+#_9662599a95471f6b573e63dcf691b7e0 | p1@ECT2 |
| 1.49e-44 | FFCP PHASE1:Hg19::chr15:56311466..56311511,+#_bdac417d2e3ac6bdf9d1cc3d43d4a5af | p@chr15:56311466..56311511, + |
| 1.49e-44 | FFCP PHASE2:Hg19::chr15:56311466..56311511,+#_bdac417d2e3ac6bdf9d1cc3d43d4a5af | p@chr15:56311466..56311511, + |
| 4.62e-44 | FFCP PHASE1:Hg19::chr12:20975516..20975562,+#_01c9631b772310c13886bcee2aaed2ce | p@chr12:20975516..20975562, + |
| 4.62e-44 | FFCP PHASE2:Hg19::chr12:20975516..20975562,+#_01c9631b772310c13886bcee2aaed2ce | p@chr12:20975516..20975562, + |
| 6.56e-42 | FFCP PHASE2:Hg19::chr15:78857870..78857897,+#_a884691d1058034c9cef3ce3e8473efb | p1@CHRNA5 |
| 6.56e-42 | FFCP PHASE1:Hg19::chr15:78857870..78857897,+#_a884691d1058034c9cef3ce3e8473efb | p1@CHRNA5 |
| 8.07e-42 | FFCP PHASE2:Hg19::chr7:96339167..96339197,-#_e6c57b5c5de9bb75947959265edc20fe | p2@SHFM1 |
| 8.07e-42 | FFCP PHASE1:Hg19::chr7:96339167..96339197,-#_e6c57b5c5de9bb75947959265edc20fe | p2@SHFM1 |
| 3.24e-41 | FFCP PHASE1:Hg19::chr1:154947148..154947175,+#_a9314f843ac941287985ff615e44b11e | p1@CKS1B |
| 3.24e-41 | FFCP PHASE2:Hg19::chr1:154947148..154947175,+#_a9314f843ac941287985ff615e44b11e | p1@CKS1B |
| 3.96e-41 | FFCP PHASE1:Hg19::chr5:34915805..34915847,+#_633a383f8705556aec1190ddd5bfb71d | p1@BRIX1 |
| 3.96e-41 | FFCP PHASE2:Hg19::chr5:34915805..34915847,+#_633a383f8705556aec1190ddd5bfb71d | p1@BRIX1 |
| 5.77e-41 | FFCP PHASE2:Hg19::chr17:36715685..36715749,-#_340e2e2094cbd602ba81d5b0182000be | p3@SRCIN1 |
| 5.77e-41 | FFCP PHASE1:Hg19::chr17:36715685..36715749,-#_340e2e2094cbd602ba81d5b0182000be | p3@SRCIN1 |
| 6.49e-41 | FFCP PHASE1:Hg19::chr7:105162652..105162709,-#_b5bf1ff3bc5994fb40ad509d3589db1e | p1@PUS7 |
| 6.49e-41 | FFCP PHASE2:Hg19::chr7:105162652..105162709,-#_b5bf1ff3bc5994fb40ad509d3589db1e | p1@PUS7 |
| 7.02e-41 | FFCP PHASE1:Hg19::chr2:54784868..54784919,+#_589ff22ede124956f3a7e112110534f3 | p@chr2:54784868..54784919, + |
| 7.02e-41 | FFCP PHASE2:Hg19::chr2:54784868..54784919,+#_589ff22ede124956f3a7e112110534f3 | p@chr2:54784868..54784919, + |
| 9.49e-41 | FFCP PHASE1:Hg19::chr2:238499725..238499747,-#_7a86feab6ec92a5007d5a1e4afaac56d | p2@RAB17 |
| 9.49e-41 | FFCP PHASE2:Hg19::chr2:238499725..238499747,-#_7a86feab6ec92a5007d5a1e4afaac56d | p2@RAB17 |
| 9.52e-41 | FFCP PHASE2:Hg19::chr13:109917833..109917866,+#_4f50b545d639545810a881464f1ec4c1 | p@chr13:109917833..109917866, + |
| 9.52e-41 | FFCP PHASE1:Hg19::chr13:109917833..109917866,+#_4f50b545d639545810a881464f1ec4c1 | p@chr13:109917833..109917866, + |
| 1.46e-40 | FFCP PHASE1:Hg19::chr8:124408630..124408647,-#_d0662a96d16202cb205a3ffff225c39e | p2@ATAD2 |
| 1.46e-40 | FFCP PHASE2:Hg19::chr8:124408630..124408647,-#_d0662a96d16202cb205a3ffff225c39e | p2@ATAD2 |
| 2.64e-40 | FFCP PHASE2:Hg19::chr4:57301645..57301675,-#_6e8e14de91aa3fd45dfd2b5d0c66ccb6 | p2@PPAT |
| 2.64e-40 | FFCP PHASE1:Hg19::chr4:57301645..57301675,-#_6e8e14de91aa3fd45dfd2b5d0c66ccb6 | p2@PPAT |
| 3.66e-40 | FFCP PHASE2:Hg19::chr5:37288836..37288849,-#_b2e8d775e4c6a1bb8f601a006fbe4f44 | p@chr5:37288836..37288849, - |
| 3.66e-40 | FFCP PHASE1:Hg19::chr5:37288836..37288849,-#_b2e8d775e4c6a1bb8f601a006fbe4f44 | p@chr5:37288836..37288849, - |
| 4.73e-40 | FFCP PHASE1:Hg19::chr22:22901636..22901715,-#_4dfe7d5511b645658a9e013c277138a9 | p1@PRAME |
| 4.73e-40 | FFCP PHASE2:Hg19::chr22:22901636..22901715,-#_4dfe7d5511b645658a9e013c277138a9 | p1@PRAME |
| 2.42e-39 | FFCP PHASE1:Hg19::chr15:69706740..69706754,+#_62031ce299723f757990be2bba890781 | p2@KIF23 |
| 2.42e-39 | FFCP PHASE2:Hg19::chr15:69706740..69706754,+#_62031ce299723f757990be2bba890781 | p2@KIF23 |
| 3.02e-39 | FFCP PHASE1:Hg19::chr7:11012953..11012969,+#_fd93e9825283cff3486fb8bc31274a63 | p@chr7:11012953..11012969, + |
| 3.02e-39 | FFCP PHASE2:Hg19::chr7:11012953..11012969,+#_fd93e9825283cff3486fb8bc31274a63 | p@chr7:11012953..11012969, + |
| 4.22e-39 | FFCP PHASE1:Hg19::chr5:37371163..37371231,-#_e87a340889538ac078ecac4b948756c4 | p1@NUP155 |
| 4.22e-39 | FFCP PHASE2:Hg19::chr5:37371163..37371231,-#_e87a340889538ac078ecac4b948756c4 | p1@NUP155 |
| 1.38e-38 | FFCP PHASE2:Hg19::chr7:56119449..56119492,+#_fc8c8b4bf62e8ccb6ad37deaf7ecad7e | p1@CCT6A |
| 1.38e-38 | FFCP PHASE1:Hg19::chr7:56119449..56119492,+#_fc8c8b4bf62e8ccb6ad37deaf7ecad7e | p1@CCT6A |
| 2.18e-38 | FFCP PHASE1:Hg19::chr17:38444115..38444194,+#_9263696c162d2231d123ddf9e9b18e19 | p1@CDC6 |
| 2.18e-38 | FFCP PHASE2:Hg19::chr17:38444115..38444194,+#_9263696c162d2231d123ddf9e9b18e19 | p1@CDC6 |
| 2.62e-38 | FFCP PHASE2:Hg19::chr7:1595831..1595858,-#_accb131c388a198f6c1ddbb4d5da638a | p1@TMEM184A |
| 2.62e-38 | FFCP PHASE1:Hg19::chr7:1595831..1595858,-#_accb131c388a198f6c1ddbb4d5da638a | p1@TMEM184A |
| 3.07e-38 | FFCP PHASE2:Hg19::chr17:62770351..62770363,-#_9e9b4deaf39a73b8d75223f7f44db7af | p@chr17:62770351..62770363, - |
| 3.07e-38 | FFCP PHASE1:Hg19::chr17:62770351..62770363,-#_9e9b4deaf39a73b8d75223f7f44db7af | p@chr17:62770351..62770363, - |
| 3.5e-38 | FFCP PHASE2:Hg19::chr2:70529150..70529179,-#_6b74e324c526b09133f3f2f842dc0905 | p1@FAM136A |
| 3.5e-38 | FFCP PHASE1:Hg19::chr2:70529150..70529179,-#_6b74e324c526b09133f3f2f842dc0905 | p1@FAM136A |
| 4.66e-38 | FFCP PHASE2:Hg19::chr12:54332608..54332636,+#_97931646101a64e4267a13fcd025e0ef | p1@HOXC13 |
| 4.66e-38 | FFCP PHASE1:Hg19::chr12:50419141..50419170,-#_97931646101a64e4267a13fcd025e0ef | p2@RACGAP1 |
| 4.66e-38 | FFCP PHASE2:Hg19::chr12:50419141..50419170,-#_97931646101a64e4267a13fcd025e0ef | p2@RACGAP1 |
| 4.66e-38 | FFCP PHASE1:Hg19::chr12:54332608..54332636,+#_97931646101a64e4267a13fcd025e0ef | p1@HOXC13 |
| 5.57e-38 | FFCP PHASE1:Hg19::chr12:118454500..118454585,+#_13d0f01f4c999c4a5f2364616fcd07d2 | p1@RFC5 |
| 5.57e-38 | FFCP PHASE2:Hg19::chr12:118454500..118454585,+#_13d0f01f4c999c4a5f2364616fcd07d2 | p1@RFC5 |
| 6.1e-38 | FFCP PHASE1:Hg19::chrX:27417088..27417131,-#_6de9539b6a44349d8d317ad1550a606a | p1@ENST00000422048, p1@uc004dbt.2 |
| 6.1e-38 | FFCP PHASE2:Hg19::chrX:27417088..27417131,-#_6de9539b6a44349d8d317ad1550a606a | p1@ENST00000422048, p1@uc004dbt.2 |
| 9.54e-38 | FFCP PHASE1:Hg19::chr11:66139128..66139152,-#_faee880c7e3dafefc5d2426004c8bda2 | p3@SLC29A2 |
| 9.54e-38 | FFCP PHASE2:Hg19::chr11:66139128..66139152,-#_faee880c7e3dafefc5d2426004c8bda2 | p3@SLC29A2 |
| 1.24e-37 | FFCP PHASE1:Hg19::chr2:198364552..198364576,-#_6f3958d46c2b8d00d02c43c18629dc16 | p1@HSPD1 |
| 1.24e-37 | FFCP PHASE2:Hg19::chr2:198364552..198364576,-#_6f3958d46c2b8d00d02c43c18629dc16 | p1@HSPD1 |
| 1.55e-37 | FFCP PHASE1:Hg19::chr2:174562443..174562467,+#_a67790d25df75c3fae09a7ab3afc5c68 | p@chr2:174562443..174562467, + |
| 1.55e-37 | FFCP PHASE2:Hg19::chr2:174562443..174562467,+#_a67790d25df75c3fae09a7ab3afc5c68 | p@chr2:174562443..174562467, + |
| 2.03e-37 | FFCP PHASE1:Hg19::chr2:29117521..29117569,+#_febc5301ad9d7acfac801688a82ea647 | p1@WDR43 |
| 2.03e-37 | FFCP PHASE2:Hg19::chr2:29117521..29117569,+#_febc5301ad9d7acfac801688a82ea647 | p1@WDR43 |
| 2.33e-37 | FFCP PHASE2:Hg19::chr17:43503012..43503035,-#_82c0944f083c2e52120ebdb31e2c3260 | p4@ARHGAP27 |
| 2.33e-37 | FFCP PHASE1:Hg19::chr17:43503012..43503035,-#_82c0944f083c2e52120ebdb31e2c3260 | p4@ARHGAP27 |
| 2.57e-37 | FFCP PHASE2:Hg19::chr16:2955389..2955405,-#_616eadb0cd1164efd51f9947857688f1 | p@chr16:2955389..2955405, - |
| 2.57e-37 | FFCP PHASE1:Hg19::chr16:2955389..2955405,-#_616eadb0cd1164efd51f9947857688f1 | p@chr16:2955389..2955405, - |
| 3.09e-37 | FFCP PHASE1:Hg19::chr1:235268802..235268805,-#_be58c527b0fde018746d6447849972de | p@chr1:235268802..235268805, - |
| 3.09e-37 | FFCP PHASE2:Hg19::chr1:235268802..235268805,-#_be58c527b0fde018746d6447849972de | p@chr1:235268802..235268805, - |
| 4.54e-37 | FFCP PHASE1:Hg19::chr5:10250349..10250362,+#_2d8ec77f3e3b38a639bb60ed5abb7351 | p2@CCT5 |
| 4.54e-37 | FFCP PHASE2:Hg19::chr5:10250349..10250362,+#_2d8ec77f3e3b38a639bb60ed5abb7351 | p2@CCT5 |
| 5.03e-37 | FFCP PHASE2:Hg19::chr3:194040598..194040638,-#_a712dcc4ebc6ef017cd020b53657a059 | p@chr3:194040598..194040638, - |
| 5.03e-37 | FFCP PHASE1:Hg19::chr3:194040598..194040638,-#_a712dcc4ebc6ef017cd020b53657a059 | p@chr3:194040598..194040638, - |
| 8.27e-37 | FFCP PHASE2:Hg19::chr7:1595804..1595828,-#_f2fda5d569a0d61899984d16d3745198 | p3@TMEM184A |
| 8.27e-37 | FFCP PHASE1:Hg19::chr7:1595804..1595828,-#_f2fda5d569a0d61899984d16d3745198 | p3@TMEM184A |
| 1.08e-36 | FFCP PHASE2:Hg19::chr10:96363899..96363904,+#_2f4812cba8b76987d543a2adf63419f1 | p@chr10:96363899..96363904, + |
| 1.08e-36 | FFCP PHASE1:Hg19::chr10:96363899..96363904,+#_2f4812cba8b76987d543a2adf63419f1 | p@chr10:96363899..96363904, + |
| 1.73e-36 | FFCP PHASE1:Hg19::chr18:47376197..47376227,-#_8552cdedfcfc121adb8a183e8f88e8ce | p2@MYO5B |
| 1.73e-36 | FFCP PHASE2:Hg19::chr18:47376197..47376227,-#_8552cdedfcfc121adb8a183e8f88e8ce | p2@MYO5B |
| 1.81e-36 | FFCP PHASE1:Hg19::chr13:114103443..114103479,-#_43a101d9ebdcc8ce216dbdbec85d4c98 | p2@ADPRHL1 |
| 1.81e-36 | FFCP PHASE2:Hg19::chr13:114103443..114103479,-#_43a101d9ebdcc8ce216dbdbec85d4c98 | p2@ADPRHL1 |
